Federal Supply Schedule 36F79720D0229
Award Date
10/1/20
Last Date to Order
9/30/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Intra-Cellular Therapies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
This is a Federal Supply Schedule (FSS) contract awarded to Assertio Therapeutics Inc. by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is for the procurement of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) GSA schedule. The contract has a ceiling value of $51,322,640.00 and a period of performance from July 1, 2020 to June 30, 2025. As a multiple...
The Federal Supply Schedule (FSS) contract identified as 36F79720D0225 was awarded by the U.S. Department of Veterans Affairs (VA) to Novartis Gene Therapies Inc. on September 15, 2020. This multiple-award, indefinite delivery vehicle (IDV) contract is under the Pharmaceuticals and Drugs (FSS-61-IB) category, with a total ceiling value of $6,000,000,000 and a period of performance extending until September 14, 2026. The purpose of this contract is to provide the VA with a broad range of...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Enzyvant Therapeutics Inc. The contract is for pharmaceutical and hematology-related products under Schedule 65 I B of the FSS program. The contract has a ceiling value of $25,000.00 and a period of performance from January 1, 2023 to June 30, 2023. As an FSS contract, this is a multiple award vehicle allowing other federal agencies to place orders against the schedule. The contract was awarded...
This Federal Supply Schedule (FSS) contract is an interim agreement awarded to Technomed, Inc. (Vendor ID: EEG2UM6DZB23) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12). The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through April 30, 2023. As a multiple-award FSS contract, this agreement provides a...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Metuchen Pharmaceuticals LLC. The contract is for Pharmaceuticals and Drugs (FSS-61-IB) and has a ceiling value of $6,800,000 with a period of performance through February 14, 2025. The contract aims to procure a variety of pharmaceutical and hematology-related products for the VA's Veterans Integrated Service Network 12. As an FSS contract, it allows for the VA and other federal agencies to...